N
NewsBot
Guest
By 2010-09-23T15:31:14ZWASHINGTON (AP) -- Federal health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks....
View the full article
View the full article